Beneficial effects in autism spectrum disorders of the Japanese food supplement Nichi-Glucan (www.nichiglucan.com), a bi...
eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...
Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (D...
The International Vaccine Institute (IVI) in South Korea has announced that the Bill & Melinda Gates Foundation has ...
Tiziana Life Sciences plc, a UK based biotechnology company focused on innovative therapeutics for oncology, inflammatio...
Guangzhou Link Health Pharma Co., Ltd. (Link Health), based in China, and Australian firm George Clinical Pty Ltd (Georg...
FUJIFILM Toyama Chemical has announced the initiation of a new phase III clinical trial in Japan concerning its anti-inf...
TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost...
United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in a study called “h...
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase...
In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibo...
Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smar...
CEPI, the Coalition for Epidemic Preparedness Innovations, based in Norway, has announced that it will fund the developm...
Asian biotech industry has been experiencing an escalating boom over the past several years. Pharmaceutical companies ha...
Daewoong Pharmaceutical announced on 26 Oct 2020 that the collaborative clinical research agreement betwe...
Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new...
APRINOIA Therapeutics advancing a pipeline featuring diagnostic and therapeutic programs, collectively targeting brain d...
The COVID Pandemic has dramatically disrupted the delivery of clinical trials. Sponsors now require instant access...
